Elisa DeStanchina
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery 1
- Biomedical Engineering top 10%
- Nanoplatforms for cancer theranostics 1
-
- Advanced biosensing and bioanalysis techniques 1
- Epigenetics and DNA Methylation 1
- Cancer-related gene regulation 1
-
- Genetics and Neurodevelopmental Disorders 1
- Co-authors
- Miriam BenezraAndrew BurnsPat ZanzonicoJedd D. WolchokErik HerzUlrich WiesnerSrikant Kamesh IyerValerie A. Longo
- Partner nations
- United States
In The Last Decade
Elisa DeStanchina
2 papers receiving 502 citations
Hit Papers
Peers
Comparison fields: 5 of 77
- Biomaterials 249
- Biomedical Engineering 276
- Materials Chemistry 173
- Pharmaceutical Science 22
- Molecular Biology 170
Countries citing papers authored by Elisa DeStanchina
This map shows the geographic impact of Elisa DeStanchina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisa DeStanchina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisa DeStanchina more than expected).
Fields of papers citing papers by Elisa DeStanchina
This network shows the impact of papers produced by Elisa DeStanchina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisa DeStanchina. The network helps show where Elisa DeStanchina may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Elisa DeStanchina, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 4 | |
| 2 | Multimodal silica nanoparticles are effective cancer-targeted probes in a model of human melanomabreakdown → | 2011 | 504 |
About Elisa DeStanchina
Elisa DeStanchina is a scholar working on Biomaterials, Genetics and Molecular Biology, having authored 2 papers that have together received 508 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (1 paper), Genetics and Neurodevelopmental Disorders (1 paper), Advanced biosensing and bioanalysis techniques (1 paper), Nanoplatforms for cancer theranostics (1 paper), Epigenetics and DNA Methylation (1 paper) and Cancer-related gene regulation (1 paper). The work is most often cited by research in Biomaterials (249 citations), Biomedical Engineering (276 citations) and Materials Chemistry (173 citations). Elisa DeStanchina has collaborated with scholars based in United States. Frequent co-authors include Miriam Benezra, Andrew Burns, Pat Zanzonico, Jedd D. Wolchok, Erik Herz, Ulrich Wiesner, Srikant Kamesh Iyer, Valerie A. Longo, Oula Peñate Medina and Steven M. Larson. Their work appears in journals such as Journal of Clinical Investigation and ACS Medicinal Chemistry Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.